Security key
501147102
Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS)
CUSIP: 501147102
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Common Stock, $0.00001 par value ("Common Stock")
- Total 13F shares
- 23,039,160
- Total 13F value
- $2,704,675,917
- Share change
- +2,069,187
- Put/Call ratio
- 86%
- SEC-reported price per share
- $117.40
- Number of holders
- 182
- Value change
- +$256,730,169
- Number of buys
- 99
- Number of sells
- 76
- Shares outstanding
- 29,463,330
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
182
Top holders
10
KRYS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Krystal Biotech, Inc. SEC filings
Krystal Biotech, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 501147102
Recent filing periods:
Ownership snapshot
Top reported holders of KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Mar 2023
13F
Lead comparable stake: 7.5%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 7.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
7.5%
Redmile Group, LLC
6.5%
Avoro Capital Advisors LLC
5.9%
BlackRock Finance, Inc.
5.8%
VANGUARD GROUP INC
4.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
7.5%
|
$175,888,457
2,196,958 shares
|
— | 31 Mar 2023 |
| Redmile Group, LLC |
13F
Company
|
6.5%
|
$153,177,197
1,913,280 shares
|
— | 31 Mar 2023 |
| Avoro Capital Advisors LLC |
13F
Company
|
5.9%
|
$140,105,000
1,750,000 shares
|
— | 31 Mar 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
5.8%
|
$137,390,566
1,716,095 shares
|
— | 31 Mar 2023 |
| VANGUARD GROUP INC |
13F
Company
|
4.1%
|
$96,250,534
1,202,230 shares
|
— | 31 Mar 2023 |
| STATE STREET CORP |
13F
Company
|
3.5%
|
$82,173,184
1,026,395 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
182
Shares
23,039,160
Rows available
182
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
159
Q2 2023 holders
182
Holder diff
23
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend